The Hobart Group is an international portfolio of medical device companies that includes over 100 scientists, engineers, regulatory and business experts. We accelerate ideas, develop and commercialize technologies targeting top medical markets with significant unmet needs and large exit potentials including cardiology, diabetes, oncology, neurology, rehabilitation and blood banking. Our clinical expertise and extensive regulatory and market knowledge spans across Europe, the US and Asia.Hobart’s founder, Professor Shlomo Ben-Haim, is a medical device entrepreneur. He has held faculty appointments as a Professor of Medicine, Physiology and Biophysics at both Harvard University and the Technion – Israel Institute of Technology, and has a an impressive record of co-founding companies and maximizing their value. Some of his notable exits include the sales of Biosense to Johnson

2006
Venture Capital
Sector
Healthcare
Medical Imaging
Oncology
Heart Imaging
Cardiology
Cardiac
AI Technology
Machine Learning
Computer Vision
Offering Type
Business Model
Software
Hardware
B2B

People

Jonathan Matus

Name

Title

Class

Ira Sobel

Name

Title

Class

Tali Gross

Name

Title

Class

Investment Portfolio

Active
2018
20

Startup

Status

Founded

Employees

News

Register Pro to view more

Pro

$50 per month

Sign up to keep browsing

You reached your pageview limit

  • Save profiles to your list
  • Basic search functionality
  • Browse our leading AI database

Select a Table to Export